Literature DB >> 3282815

Preoperative radioactive therapy for esophageal carcinoma. Randomized evaluation trial in eight institutions.

T Iizuka1, H Ide, T Kakegawa, K Sasaki, I Takagi, N Ando, S Mori, M Arimori, S Tsugane.   

Abstract

A cooperative, prospective, randomized study to evaluate the effectiveness of preoperative irradiation in curatively resected esophageal carcinoma was performed in 364 cases in eight institutions from August 1982 to November, 1983. Based on the survival curves, postoperative irradiation alone was superior to preoperative plus postoperative irradiation. Because of the progression of the disease and complications after operation, there were many inevaluable cases in this study. However, analysis revealed there was no bias caused by a greater number of unfavorable patients being selectively included in inevaluable cases in the postoperative irradiation only group. Our data question the value of preoperative irradiation being performed in addition to resection plus postoperative irradiation.

Entities:  

Mesh：

Year:  1988        PMID： 3282815     DOI： 10.1378/chest.93.5.1054

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  15 in total

1.  Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years.

Authors:  N Ando; S Ozawa; Y Kitagawa; Y Shinozawa; M Kitajima
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

Review 2.  Squamous cell carcinoma of the oesophagus: 10 years on.

Authors:  G A Khoury
Journal:  Ann R Coll Surg Engl       Date:  1991-01       Impact factor: 1.891

3.  Improved surgical results in thoracic esophageal squamous cell carcinoma: a 40-year analysis of 792 patients.

Authors:  Hideaki Shimada; Hisahiro Matsubara; Shinichi Okazumi; Kaichi Isono; Takenori Ochiai
Journal:  J Gastrointest Surg       Date:  2007-09-01       Impact factor: 3.452

Review 4.  Neoadjuvant therapy for advanced esophageal cancer: the impact on surgical management.

Authors:  Masahiko Ikebe; Masaru Morita; Manabu Yamamoto; Yasushi Toh
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-05-10

Review 5.  Adjuvant therapies for cancer of the thoracic esophagus.

Authors:  T Nishihira; T Nakano; S Mori
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

6.  Clinical evaluation of adjuvant chemoradiotherapy with CDDP, 5-FU, and VP-16 for advanced esophageal cancer.

Authors:  H Mukaida; T Hirai; Y Yamashita; K Yoshida; J Hihara; M Kuwahara; H Inoue; T Toge
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-01

7.  Esophageal resection and by-pass: a 6 year experience with a low postoperative mortality.

Authors:  J M Collard; J B Otte; M Reynaert; L Michel; M A Carlier; P J Kestens
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352

8.  5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. A multicenter randomized trial. French Associations for Surgical Research.

Authors:  X Pouliquen; H Levard; J M Hay; K McGee; A Fingerhut; O Langlois-Zantin
Journal:  Ann Surg       Date:  1996-02       Impact factor: 12.969

Review 9.  Current Advancement in Multidisciplinary Treatment for Resectable cStage II/III Esophageal Squamous Cell Carcinoma in Japan.

Authors:  Satoru Matsuda; Hiroya Takeuchi; Hirofumi Kawakubo; Nobutoshi Ando; Yuko Kitagawa
Journal:  Ann Thorac Cardiovasc Surg       Date:  2016-07-06       Impact factor: 1.520

10.  Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study.

Authors:  H U Zieren; J M Müller; C A Jacobi; H Pichlmaier; R P Müller; S Staar
Journal:  World J Surg       Date:  1995 May-Jun       Impact factor: 3.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.